https://orcid.org/0000-0002-2633-9067
Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marco Infante, Camillo Ricordi, Rodolfo Alejandro, Massimiliano Caprio & Andrea Fabbri. (2021) Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection. Expert Review of Anti-infective Therapy 19:1, pages 5-16.
Read now
Read now
Shahla Shojaei, Madhumita Suresh, Daniel J. Klionsky, Hagar Ibrahim Labouta & Saeid Ghavami. (2020) Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway. Virulence 11:1, pages 805-810.
Read now
Read now
Articles from other publishers (32)
Elahe Nasri, Hamed Fakhim, Mehrdad Salahi, Safiyeh Ghafel, Samane Pourajam, Ali Darakhshandeh, Nazila Kassaian, Somayeh Sadeghi, Behrooz Ataei, ShaghayeghHaghjooy Javanmard & Afsane Vaezi. (2023) Efficacy of hydroxychloroquine in pre-exposure severe acute respiratory syndrome coronavirus 2 prophylaxis among high-risk healthcare workers: A multicenter study. Advanced Biomedical Research 12:1, pages 3.
Crossref
Crossref
Asmaa M. Taha, Wafaa S. Hassan, Manal S. Elmasry & Rania A. Sayed. (2023) A validated eco-friendly HPLC-FLD for analysis of the first approved antiviral remdesivir with other potential add-on therapies for COVID-19 in human plasma and pharmaceuticals. Analytical Methods.
Crossref
Crossref
Orhan E. Arslan. 2023. Viral Drug Delivery Systems. Viral Drug Delivery Systems
311
338
.
Rahul Bhattacharjee, Ankit Kumar Dubey, Archisha Ganguly, Basudha Bhattacharya, Yogendra Kumar Mishra, Ebrahim Mostafavi & Ajeet Kaushik. (2022) State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic. OpenNano 8, pages 100078.
Crossref
Crossref
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin & Soheila Molaei. (2022) Can anti-parasitic drugs help control COVID-19?. Future Virology 17:5, pages 315-339.
Crossref
Crossref
Tuyen N. Tran & Maged Henary. (2022) Synthesis and Applications of Nitrogen-Containing Heterocycles as Antiviral Agents. Molecules 27:9, pages 2700.
Crossref
Crossref
Pooja Dhupkar & Seema Mukherjee. (2021) Ethical dimensions in randomized trials and off-label use of investigational drugs for COVID-19 treatment. Clinical Ethics 17:1, pages 95-104.
Crossref
Crossref
Xiaojia Zhu, Yuwei Wang, Yujie Xiao, Qianwen Gao, Li Gao, Wenhui Zhang, Xiaofeng Xin, Kesu Chen, Ujala Srivastava, Vamsi Krishna Murthy Ginjupalli, Michael Cupelli, Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Long Chen & Mohamed Boutjdir. (2022) Arrhythmogenic mechanisms of interleukin-6 combination with hydroxychloroquine and azithromycin in inflammatory diseases. Scientific Reports 12:1.
Crossref
Crossref
L.L. Albornoz, V.D. Soroka & M.C.A. Silva. (2021) Photo-mediated and advanced oxidative processes applied for the treatment of effluents with drugs used for the treatment of early COVID-19: Review. Environmental Advances 6, pages 100140.
Crossref
Crossref
Mohitosh Biswas & Debendra Nath Roy. (2021) Potential clinically significant drug‐drug interactions of hydroxychloroquine used in the treatment of COVID‐19. International Journal of Clinical Practice 75:11.
Crossref
Crossref
Hesham A. Saafan, Kamilia M. Ibrahim, Yasmeena Thabet, Sara M. Elbeltagy, Rana A. Eissa, Ashraf H. Ghaleb, Fathy Ibrahim, Mahmoud Elsabahy & Noura G. Eissa. (2021) Intratracheal Administration of Chloroquine-Loaded Niosomes Minimize Systemic Drug Exposure. Pharmaceutics 13:10, pages 1677.
Crossref
Crossref
Elangovan Manivannan, Chandrabose Karthikeyan, N. S. Hari Narayana Moorthy & Subash Chandra Chaturvedi. (2021) The Rise and Fall of Chloroquine/Hydroxychloroquine as Compassionate Therapy of COVID-19. Frontiers in Pharmacology 12.
Crossref
Crossref
Ronghua Ding, Jinzhao Long, Mingzhu Yuan, Yuefei Jin, Haiyan Yang, Mengshi Chen, Shuaiyin Chen & Guangcai Duan. (2021) CRISPR/Cas System: A Potential Technology for the Prevention and Control of COVID-19 and Emerging Infectious Diseases. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Veer Singh & Vishal Mishra. (2021) Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options. Coronaviruses 2:4, pages 481-491.
Crossref
Crossref
Saba Farooq & Zainab Ngaini. (2020) Natural and Synthetic Drugs as Potential Treatment for Coronavirus Disease 2019 (COVID-2019). Chemistry Africa 4:1, pages 1-13.
Crossref
Crossref
Mehmet Sinan Beksac & Hanife Guler Donmez. (2020) Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug. Journal of Obstetrics and Gynaecology Research 47:2, pages 570-575.
Crossref
Crossref
S. Verheijen, M. van Luin, R.J. Brüggemann, Q. de Mast, R.J. Hassing & D.M. Burger. (2021) More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine. International Journal of Infectious Diseases 103, pages 402-403.
Crossref
Crossref
Hussain Ahmed Raza, Javeria Tariq, Vikas Agarwal & Latika Gupta. (2021) COVID-19, hydroxychloroquine and sudden cardiac death: implications for clinical practice in patients with rheumatic diseases. Rheumatology International 41:2, pages 257-273.
Crossref
Crossref
José Romério Rabelo Melo, Elisabeth Carmen Duarte, Marcelo Vogler de Moraes, Karen Fleck, Amanda Soares do Nascimento e Silva & Paulo Sérgio Dourado Arrais. (2021) Reações adversas a medicamentos em pacientes com COVID-19 no Brasil: análise das notificações espontâneas do sistema de farmacovigilância brasileiro. Cadernos de Saúde Pública 37:1.
Crossref
Crossref
Iqbal Hussain, Afzal Hussain, Mohamed F. Alajmi, Md. Tabish Rehman & Samira Amir. (2021) Impact of repurposed drugs on the symptomatic COVID-19 patients. Journal of Infection and Public Health 14:1, pages 24-38.
Crossref
Crossref
Amany A. Sarhan, Nada A. Ashour & Ahmed A. Al‐Karmalawy. (2021) The journey of antimalarial drugs against SARS-CoV-2: Review article. Informatics in Medicine Unlocked 24, pages 100604.
Crossref
Crossref
Stephen D. Carro & Sara Cherry. (2020) Beyond the Surface: Endocytosis of Mosquito-Borne Flaviviruses. Viruses 13:1, pages 13.
Crossref
Crossref
Allan Giri, Ankita Das, Ajoy K. Sarkar & Ashok K. Giri. (2020) Mutagenic, Genotoxic and Immunomodulatory effects of Hydroxychloroquine and Chloroquine: a review to evaluate its potential to use as a prophylactic drug against COVID-19. Genes and Environment 42:1.
Crossref
Crossref
Xueting Yao, Zhe Hou, Cheng Cui, Miao Zhang, Siqi Tu, Haiyan Li & Dongyang Liu. (2020) Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population. Current Drug Metabolism 21:7, pages 534-540.
Crossref
Crossref
Lígia N de M Ribeiro & Belchiolina B Fonseca. (2020) The role of pharmaceutical nanotechnology in the time of COVID-19 pandemic. Future Microbiology 15:16, pages 1571-1582.
Crossref
Crossref
Alireza Paniri, Mohammad Mahdi Hosseini, Ahmad Rasoulinejad & Haleh Akhavan-Niaki. (2020) Molecular effects and retinopathy induced by hydroxychloroquine during SARS-CoV-2 therapy: Role of CYP450 isoforms and epigenetic modulations. European Journal of Pharmacology 886, pages 173454.
Crossref
Crossref
Dongyuan Wang, Zigang Li & Yihui Liu. (2020) An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics. Journal of Infection and Public Health 13:10, pages 1405-1414.
Crossref
Crossref
Zachary Sanford, Ronson J. Madathil, Kristopher B. Deatrick, Ali Tabatabai, Jay Menaker, Samuel M. Galvagno, Michael A. Mazzeffi, Joseph Rabin, Mehrdad Ghoreishi, Raymond Rector, Daniel L. Herr & David J. Kaczorowski. (2020) Extracorporeal Membrane Oxygenation for COVID-19. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 15:4, pages 306-313.
Crossref
Crossref
Chao Jiang, Xingang Yao, Yulin Zhao, Jianmin Wu, Pan Huang, Chunhua Pan, Shuwen Liu & Chungen Pan. (2020) Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season. Microbes and Infection 22:6-7, pages 236-244.
Crossref
Crossref
B. Schoser, P. Baum, M. Boentert, K-U. Dillmann, A. Emmer, S. Knauss, E. Enax-Krumova, J. Grosskreutz, A-K. Güttsches, K. Hellwig, K. Holzapfel, C. Kornblum, H. Lehmann, A. Melms, T. Meyer, S. Petri, L. Pilgram, K. Reiners, A. Saak, J. Schäfer, J. Schmidt, C. Schneider-Gold, M. Schons, P. P. Urban, M. Vorgerd, P. Young & S Zierz. (2020) SARS-CoV-2/COVID-19 und neuromuskuläre ErkrankungenSARS-CoV-2/COVID-19 and neuromuscular disorders. DGNeurologie 3:4, pages 310-320.
Crossref
Crossref
Maryam Sefidgarnia, Susan Salari & Kamaledin Alaedini. (2020) QT Interval Prolongation in COVID-19 Patients on Methadone Treatment. Iranian Journal of Psychiatry and Behavioral Sciences 14:2.
Crossref
Crossref
V. S. Smirnov & Areg A. Totolian. (2020) Some opportunities for immunotherapy in coronavirus infection. Russian Journal of Infection and Immunity 10:3, pages 446-458.
Crossref
Crossref